Dean Y. Li
Executive VP & President, MRL at Merck & Co.; Director at Recursion Pharmaceuticals. Based in Salt Lake City, Utah.
- Rank
- 4829th of 14,644
- Companies held
- 2
- Largest holding
- MRK, 57.2% of total
- Latest SEC filing
- Oct 1, 2026
What the $21.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Merck & Co. MRK Common Stock | Directly | 94,431 | $132.81 | $12.5M | 57.2% | Form 4, May 5, 2026 |
| Recursion Pharmaceuticals RXRX Class A Common Stock | Directly | 1,476,707 | $2.72 | $4.0M | 18.3% | Form 4, Oct 1, 2026 |
| Recursion Pharmaceuticals RXRX Class A Common Stock | Through Dean Y. Li Revocable Trust | 1,422,048 | $2.72 | $3.9M | 17.6% | Form 4, Oct 1, 2026 |
| Recursion Pharmaceuticals RXRX Class A Common Stock | Through Dean Y. Li 2021 Family Trust | 421,000 | $2.72 | $1.1M | 5.2% | Form 4, Oct 1, 2026 |
| Recursion Pharmaceuticals RXRX Class A Common Stock | Through Dean Y. Li GRAT | 136,981 | $2.72 | $373K | 1.7% | Form 4, Apr 1, 2026 |
Share counts are the amounts Dean Y. Li reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4826 | John E. Capps Of Counsel, Element Solutions. Miami Beach, FL | $22.0M |
| 4827 | John R. Erickson Head of Affiliate Engagement, Affiliated Managers Group. West Palm Beach, FL | $22.0M |
| 4828 | Staffan Encrantz Director, Sight Sciences. Menlo Park, CA | $21.9M |
| 4829 | Dean Y. Li Executive VP & President, MRL, Merck & Co.. Salt Lake City, UT | $21.9M |
| 4830 | J. Kevin Willis SVP and CFO, Ashland. North Charleston, SC | $21.9M |
| 4831 | Roman Regelman Sr. Executive Vice President, The Bank of New York Mellon. New York, NY | $21.9M |
| 4832 | Rajeeb Hazra President & CEO, Quantinuum. Broomfield, CO | $21.9M |
Other Merck & Co. insiders
All MRK insiders- Kenneth C. Frazier$94.2MExecutive Chair. #1564 overall
- Robert M. Davis$59.8MChairman, CEO & President. #2190 overall
- Sanat Chattopadhyay$34.3MExe V-P & Pres. MMD. #3388 overall
- Richard R. DeLuca, Jr$15.4MEVP&Pres, Merck Animal Heallth. #6321 overall
- Caroline Litchfield$12.3MEVP & CFO. #7541 overall
- Julie L. Gerberding$6.5MEVP, Chief Patient Officer. #12086 overall
Questions
How much stock does Dean Y. Li own?
Dean Y. Li holds $21,943,710 in listed stock based on SEC filings and current prices, mostly Merck & Co. (MRK). That ranks 4829th on the Stock Rich List.
Is this Dean Y. Li's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Dean Y. Li last buy or sell stock?
The most recent open-market trade on file is a sale of 10,235 MRK shares on Feb 10, 2026 at $117.52.